European Archives - Page 184 of 1114 - European Medical Journal

white house on blue background

What does Trump's win mean for pharma?

With Donald Trump securing a second presidential term, what issues should be top of mind for the pharmaceutical sector in the US?

Higher Risk of Mortality in Young Patients Undergoing TAVR

Patients under 65 years undergoing TAVR exhibit a higher comorbidity burden and greater all-cause mortality

Blood Flow Restriction Therapy Boosts Knee Osteoarthritis Rehabilitation Outcomes

Adding blood flow restriction to knee osteoarthritis exercises significantly boosts pain relief, strength, and quality of life, new study shows.

Oophorectomy Common During Gender-Affirming Hysterectomy

New research identifies the factors associated with opting for bilateral oophorectomy versus ovarian conservation in young adults undergoing gender-affirming hysterectomy

Health Insurance Impact on Cancer Disparities Among Racial and Ethnic Groups

A recent analysis of the National Cancer Database reveals that health insurance plays a crucial role in racial and ethnic disparities in late-stage cancer diagnoses.

Alarming Diabetes Spike Following Paediatric COVID-19 Infection

Recent findings reveal a concerning link between COVID-19 and increased risk of new Type 2 diabetes diagnoses in children and adolescents.

New Algorithm Uncovers Hidden Obesity Subtypes Linked to Severe Health Risks

Obesity, defined as abnormal or excessive fat accumulation, has more than doubled among adults since 1990

New Model Boosts Personalised Care for Severe Psoriasis

A recent study from 12 hospitals across China has shed new light on personalised care for plaque psoriasis.

Therapeutic Advances in GI Cancers: Immuno-Oncology and Beyond

At the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, the latest advancements in immunotherapy for…

Onc Now: Episode 4: The Role of RNA in Oncology – Part 1

This week, Jonathan Sackier is joined by Sarah Blagden, a pioneer of experimental oncology research, and CEO of RNA Guardian Ltd, a biotechnology company dedicated to identifying early cancer biomarkers.